SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System

As part of the U.S. Food and Drug Administration COVID-19 vaccine review process, public commentary was solicited offering an opportunity to reflect on vaccine attitudes that may impact the uptake of coronavirus vaccines. We identified themes in the commentary that highlighted the safety, efficacy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Weitzman, Elissa R., Sherman, Amy C., Levy, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322674/
https://www.ncbi.nlm.nih.gov/pubmed/34336774
http://dx.doi.org/10.3389/fpubh.2021.695807
_version_ 1783731102858346496
author Weitzman, Elissa R.
Sherman, Amy C.
Levy, Ofer
author_facet Weitzman, Elissa R.
Sherman, Amy C.
Levy, Ofer
author_sort Weitzman, Elissa R.
collection PubMed
description As part of the U.S. Food and Drug Administration COVID-19 vaccine review process, public commentary was solicited offering an opportunity to reflect on vaccine attitudes that may impact the uptake of coronavirus vaccines. We identified themes in the commentary that highlighted the safety, efficacy, ethics, and trustworthiness and transparency regarding the novel mRNA COVID-19 vaccines. A “Learning Immunization System” model is proposed to optimize public, private, and academic partnerships relating to vaccine development and implementation.
format Online
Article
Text
id pubmed-8322674
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83226742021-07-31 SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System Weitzman, Elissa R. Sherman, Amy C. Levy, Ofer Front Public Health Public Health As part of the U.S. Food and Drug Administration COVID-19 vaccine review process, public commentary was solicited offering an opportunity to reflect on vaccine attitudes that may impact the uptake of coronavirus vaccines. We identified themes in the commentary that highlighted the safety, efficacy, ethics, and trustworthiness and transparency regarding the novel mRNA COVID-19 vaccines. A “Learning Immunization System” model is proposed to optimize public, private, and academic partnerships relating to vaccine development and implementation. Frontiers Media S.A. 2021-07-16 /pmc/articles/PMC8322674/ /pubmed/34336774 http://dx.doi.org/10.3389/fpubh.2021.695807 Text en Copyright © 2021 Weitzman, Sherman and Levy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Weitzman, Elissa R.
Sherman, Amy C.
Levy, Ofer
SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
title SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
title_full SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
title_fullStr SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
title_full_unstemmed SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
title_short SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System
title_sort sars-cov-2 mrna vaccine attitudes as expressed in u.s. fda public commentary: need for a public-private partnership in a learning immunization system
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322674/
https://www.ncbi.nlm.nih.gov/pubmed/34336774
http://dx.doi.org/10.3389/fpubh.2021.695807
work_keys_str_mv AT weitzmanelissar sarscov2mrnavaccineattitudesasexpressedinusfdapubliccommentaryneedforapublicprivatepartnershipinalearningimmunizationsystem
AT shermanamyc sarscov2mrnavaccineattitudesasexpressedinusfdapubliccommentaryneedforapublicprivatepartnershipinalearningimmunizationsystem
AT levyofer sarscov2mrnavaccineattitudesasexpressedinusfdapubliccommentaryneedforapublicprivatepartnershipinalearningimmunizationsystem

Ejemplares similares